While tyrosine kinase inhibitors (TKIs) have transformed CP-CML management, limited data exist on their use in clinical practice.
Treatment Patterns in Patients with Chronic-Phase Chronic Myeloid Leukaemia in Routine Clinical Practice: the SIMPLICITY Italian Population / Abruzzese, Elisabetta; Bosi, Alberto; Breccia, Massimo; D'Adda, Mariella; Di Renzo, Nicola; Liberati, Anna Marina; Porrini, Raffaele; Orlandi, Ester Maria; Pane, Fabrizio; Pungolino, Ester; Sorà, Federica; Stagno, Fabio; Sen, Ginny P; Gentilini, Fabiana; De Solda, Francesco; Gambacorti-Passerini, Carlo. - In: MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. - ISSN 2035-3006. - STAMPA. - 11:(2019), pp. e2019025-027. [10.4084/MJHID.2019.025]
Treatment Patterns in Patients with Chronic-Phase Chronic Myeloid Leukaemia in Routine Clinical Practice: the SIMPLICITY Italian Population
Bosi, AlbertoInvestigation
;
2019
Abstract
While tyrosine kinase inhibitors (TKIs) have transformed CP-CML management, limited data exist on their use in clinical practice.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
